- Clinical and translational research in lymphoma, with a focus on stem cell transplantation and development of novel therapies, as well as late effects of treatment
- Applied molecular oncology
R Michael Crump
Am J Kidney Dis. 2017 Jun 22;:
Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma.
Leuk Lymphoma. 2017 May 15;:1-8
Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study().
Leuk Lymphoma. 2017 May 15;:1-9
A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma.
Br J Haematol. 2017 Apr 25;:
Lancet Oncol. 2017 Feb 22;:
The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation options.
Support Care Cancer. 2017 Feb 02;:
J Clin Oncol. 2016 Jan 20;34(3_suppl):199
Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the Phase III CCTG LY.12 Trial.
Ann Oncol. 2016 Dec 19;:
J Natl Cancer Inst. 2016 Dec;108(12):
Hematol Oncol Clin North Am. 2016 Dec;30(6):1195-1213
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre